{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:13:17Z","timestamp":1782846797831,"version":"3.54.5"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Natural Sciences and Engineering Research Council via a Discovery","award":["#RGPIN-2021-02680"],"award-info":[{"award-number":["#RGPIN-2021-02680"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#363288"],"award-info":[{"award-number":["#363288"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The goal of precision oncology is to tailor treatment for patients individually using the genomic profile of their tumors. Pharmacogenomics datasets such as cancer cell lines are among the most valuable resources for drug sensitivity prediction, a crucial task of precision oncology. Machine learning methods have been employed to predict drug sensitivity based on the multiple omics data available for large panels of cancer cell lines. However, there are no comprehensive guidelines on how to properly train and validate such machine learning models for drug sensitivity prediction. In this paper, we introduce a set of guidelines for different aspects of training gene expression-based predictors using cell line datasets. These guidelines provide extensive analysis of the generalization of drug sensitivity predictors and challenge many current practices in the community including the choice of training dataset and measure of drug sensitivity. The application of these guidelines in future studies will enable the development of more robust preclinical biomarkers.<\/jats:p>","DOI":"10.1093\/bib\/bbab294","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T15:12:23Z","timestamp":1626102743000},"source":"Crossref","is-referenced-by-count":61,"title":["Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0515-9267","authenticated-orcid":false,"given":"Hossein","family":"Sharifi-Noghabi","sequence":"first","affiliation":[{"name":"School of Computing Science, Simon Fraser University, Burnaby, British Columbia, Canada"},{"name":"Vancouver Prostate Center, Vancouver, British Columbia, Canada"},{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Jahangiri-Tazehkand","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"},{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Smirnov","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"},{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Hon","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"},{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Mammoliti","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"},{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisira Kadambat","family":"Nair","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind Singh","family":"Mer","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"},{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ester","sequence":"additional","affiliation":[{"name":"School of Computing Science, Simon Fraser University, Burnaby, British Columbia, Canada"},{"name":"Vancouver Prostate Center, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-0079","authenticated-orcid":false,"given":"Benjamin","family":"Haibe-Kains","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"},{"name":"Ontario Institute for Cancer Research, Toronto, Ontario, Canada"},{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"2021110815072724900_ref1","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2013.49.4799","article-title":"Precision oncology: an overview","volume":"31","author":"Garraway","year":"2013","journal-title":"J Clin Oncol"},{"key":"2021110815072724900_ref2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drup.2017.02.002","article-title":"Drug-biomarker co-development in oncology \u221220 years and counting","volume":"30","author":"Twomey","year":"2017","journal-title":"Drug Resist Updat"},{"key":"2021110815072724900_ref3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1200\/JCO.18.02037","article-title":"Clinical cancer advances 2019: annual report on progress against Cancer from the American Society of Clinical Oncology","volume":"37","author":"Pal","year":"2019","journal-title":"J Clin Oncol"},{"key":"2021110815072724900_ref4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamaoncol.2018.1660","article-title":"Estimation of the percentage of US patients with Cancer who benefit from genome-driven oncology","volume":"4","author":"Marquart","year":"2018","journal-title":"JAMA Oncol"},{"key":"2021110815072724900_ref5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"key":"2021110815072724900_ref6","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing connectivity in a large-scale small-molecule sensitivity dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov"},{"key":"2021110815072724900_ref7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"2021110815072724900_ref8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in Cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"2021110815072724900_ref9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2021110815072724900_ref10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A comprehensive transcriptional portrait of human cancer cell lines","volume":"33","author":"Klijn","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2021110815072724900_ref11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature17987","article-title":"Reproducible pharmacogenomic profiling of cancer cell line panels","volume":"533","author":"Haverty","year":"2016","journal-title":"Nature"},{"key":"2021110815072724900_ref12","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat Med"},{"key":"2021110815072724900_ref13","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1158\/0008-5472.CAN-19-0349","article-title":"Integrative pharmacogenomics analysis of patient-derived xenografts","volume":"79","author":"Mer","year":"2019","journal-title":"Cancer Res"},{"key":"2021110815072724900_ref14","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","article-title":"Organoid cultures as preclinical models of non-small cell lung Cancer","volume":"26","author":"Shi","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2021110815072724900_ref15","doi-asserted-by":"crossref","first-page":"D994","DOI":"10.1093\/nar\/gkx911","article-title":"PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies","volume":"46","author":"Smirnov","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021110815072724900_ref16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature12831","article-title":"Inconsistency in large pharmacogenomic studies","volume":"504","author":"Haibe-Kains","year":"2013","journal-title":"Nature"},{"key":"2021110815072724900_ref17","first-page":"5","article-title":"Revisiting inconsistency in large pharmacogenomic studies","volume":"2016","author":"Safikhani","year":"2333","journal-title":"F1000Res"},{"key":"2021110815072724900_ref18","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature19838","article-title":"Consistency in large pharmacogenomic studies","volume":"540","author":"Geeleher","year":"2016","journal-title":"Nature"},{"key":"2021110815072724900_ref19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature15736","article-title":"Pharmacogenomic agreement between two cancer cell line data sets","volume":"528","author":"Cancer Cell Line Encyclopedia Consortium, Genomics of Drug Sensitivity in Cancer Consortium","year":"2015","journal-title":"Nature"},{"key":"2021110815072724900_ref20","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1038\/nature20171","article-title":"Consistency in drug response profiling","volume":"540","author":"Mpindi","year":"2016","journal-title":"Nature"},{"key":"2021110815072724900_ref21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cels.2019.06.005","article-title":"A multi-center study on the reproducibility of drug-response assays in mammalian cell lines","volume":"9","author":"Niepel","year":"2019","journal-title":"Cell Syst"},{"key":"2021110815072724900_ref22","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1038\/nature20580","article-title":"Drug response consistency in CCLE and CGP","volume":"540","author":"Bouhaddou","year":"2016","journal-title":"Nature"},{"key":"2021110815072724900_ref23","article-title":"ORCESTRA: a platform for orchestrating and sharing high-throughput pharmacogenomic analyses","author":"Mammoliti","year":"2020","journal-title":"Cold Spring Harbor Laboratory"},{"key":"2021110815072724900_ref24","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkaa968","article-title":"CellMiner Cross-Database (CellMinerCDB) version 1.2: exploration of patient-derived cancer cell line pharmacogenomics","volume":"49","author":"Luna","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2021110815072724900_ref25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41698-020-0122-1","article-title":"Machine learning approaches to drug response prediction: challenges and recent progress","volume":"4","author":"Adam","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"2021110815072724900_ref26","article-title":"A survey and systematic assessment of computational methods for drug response prediction","volume":"22","author":"Chen","year":"2020","journal-title":"Brief Bioinform"},{"key":"2021110815072724900_ref27","article-title":"Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches","volume":"22","author":"G\u00fcven\u00e7 Paltun","year":"2019","journal-title":"Brief Bioinform"},{"key":"2021110815072724900_ref28","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol"},{"key":"2021110815072724900_ref29","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1101\/gr.221077.117","article-title":"Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies","volume":"27","author":"Geeleher","year":"2017","journal-title":"Genome Res"},{"key":"2021110815072724900_ref30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007607","article-title":"Tissue-guided LASSO for prediction of clinical drug response using preclinical samples","volume":"16","author":"Huang","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"2021110815072724900_ref31","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/bioinformatics\/btw344","article-title":"Evaluating the molecule-based prediction of clinical drug responses in cancer","volume":"32","author":"Ding","year":"2016","journal-title":"Bioinformatics"},{"key":"2021110815072724900_ref32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/bioinformatics\/btq628","article-title":"Predicting in vitro drug sensitivity using random forests","volume":"27","author":"Riddick","year":"2011","journal-title":"Bioinformatics"},{"key":"2021110815072724900_ref33","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nbt.2877","article-title":"A community effort to assess and improve drug sensitivity prediction algorithms","volume":"32","author":"Costello","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2021110815072724900_ref34","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/bioinformatics\/bty132","article-title":"Kernelized rank learning for personalized drug recommendation","volume":"34","author":"He","year":"2018","journal-title":"Bioinformatics"},{"key":"2021110815072724900_ref35","doi-asserted-by":"crossref","first-page":"i510","DOI":"10.1093\/bioinformatics\/btz372","article-title":"PRECISE: a domain adaptation approach to transfer predictors of drug response from pre-clinical models to tumors","volume":"35","author":"Mourragui","year":"2019","journal-title":"Bioinformatics"},{"key":"2021110815072724900_ref36","doi-asserted-by":"crossref","DOI":"10.1101\/2020.06.29.177139","article-title":"Predicting clinical drug response from model systems by non-linear subspace-based transfer learning.","volume-title":"bioRxiv","author":"Mourragui"},{"key":"2021110815072724900_ref37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/1541-7786.MCR-17-0378","article-title":"Precision oncology beyond targeted therapy: combining omics data with machine learning matches the majority of cancer cells to effective therapeutics","volume":"16","author":"Ding","year":"2018","journal-title":"Mol Cancer Res"},{"key":"2021110815072724900_ref38","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1093\/bioinformatics\/btz158","article-title":"Dr.VAE: improving drug response prediction via modeling of drug perturbation effects","volume":"35","author":"Ramp\u00e1\u0161ek","year":"2019","journal-title":"Bioinformatics"},{"key":"2021110815072724900_ref39","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.celrep.2019.11.017","article-title":"A deep learning framework for predicting response to therapy in cancer","volume":"29","author":"Sakellaropoulos","year":"2019","journal-title":"Cell Rep"},{"key":"2021110815072724900_ref40","doi-asserted-by":"crossref","first-page":"i501","DOI":"10.1093\/bioinformatics\/btz318","article-title":"MOLI: multi-omics late integration with deep neural networks for drug response prediction","volume":"35","author":"Sharifi-Noghabi","year":"2019","journal-title":"Bioinformatics"},{"key":"2021110815072724900_ref41","doi-asserted-by":"crossref","first-page":"i380","DOI":"10.1093\/bioinformatics\/btaa442","article-title":"AITL: adversarial inductive transfer learning with input and output space adaptation for pharmacogenomics","volume":"36","author":"Sharifi-Noghabi","year":"2020","journal-title":"Bioinformatics"},{"key":"2021110815072724900_ref42","article-title":"BDKANN - biological domain knowledge-based artificial neural network for drug response prediction","volume":"840553","author":"Snow","year":"2020","journal-title":"Cold Spring Harbor Laboratory"},{"key":"2021110815072724900_ref43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","article-title":"Predicting drug response and synergy using a deep learning model of human cancer cells","volume":"38","author":"Kuenzi","year":"2020","journal-title":"Cancer Cell"},{"key":"2021110815072724900_ref44","doi-asserted-by":"crossref","first-page":"18040","DOI":"10.1038\/s41598-020-74921-0","article-title":"Ensemble transfer learning for the prediction of anti-cancer drug response","volume":"10","author":"Zhu","year":"2020","journal-title":"Sci Rep"},{"key":"2021110815072724900_ref45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-030-45257-5_18","article-title":"Paccmann rl: designing anticancer drugs from transcriptomic data via reinforcement learning","author":"Born","year":"2020","journal-title":"International Conference on Research in Computational Molecular Biology"},{"key":"2021110815072724900_ref46","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-020-00169-2","article-title":"Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients","volume":"2","author":"Ma","year":"2021","journal-title":"Nature Cancer"},{"issue":"11","key":"2021110815072724900_ref47","first-page":"17.385757","article-title":"DrugOrchestra: Jointly predicting drug response, targets, and side effects via deep multi-task learning","volume":"2020","author":"Jiang","year":"2020","journal-title":"Cold Spring Harbor Laboratory"},{"key":"2021110815072724900_ref48","first-page":"63","article-title":"Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data","volume":"2014","author":"Jang","year":"2013","journal-title":"Biocomputing"},{"key":"2021110815072724900_ref49","doi-asserted-by":"crossref","article-title":"A cross-study analysis of drug response prediction in cancer cell lines","author":"Xia","DOI":"10.1093\/bib\/bbab356"},{"key":"2021110815072724900_ref50","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/bioinformatics\/btv723","article-title":"PharmacoGx: an R package for analysis of large pharmacogenomic datasets","volume":"32","author":"Smirnov","year":"2016","journal-title":"Bioinformatics"},{"key":"2021110815072724900_ref51","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nbt0816-888d","article-title":"Erratum: Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"key":"2021110815072724900_ref52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm Stat"},{"key":"2021110815072724900_ref53","article-title":"Tissue specificity of in vitro drug sensitivity","volume":"25","author":"Yao","year":"2017","journal-title":"J Am Med Inform Assoc"},{"key":"2021110815072724900_ref54","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41467-021-22170-8","article-title":"Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs","volume":"12","author":"Gerdes","year":"2021","journal-title":"Nat Commun"},{"key":"2021110815072724900_ref55","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2021110815072724900_ref56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1142\/S0219720005001004","article-title":"Minimum redundancy feature selection from microarray gene expression data","volume":"3","author":"Ding","year":"2005","journal-title":"J Bioinform Comput Biol"},{"key":"2021110815072724900_ref57","doi-asserted-by":"crossref","first-page":"51619","DOI":"10.18632\/oncotarget.10010","article-title":"Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies","volume":"7","author":"Pozdeyev","year":"2016","journal-title":"Oncotarget"},{"key":"2021110815072724900_ref58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.3853","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"13","author":"Hafner","year":"2016","journal-title":"Nat Methods"},{"key":"2021110815072724900_ref59","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nbt.3882","article-title":"Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics","volume":"35","author":"Hafner","year":"2017","journal-title":"Nat Biotechnol"},{"key":"2021110815072724900_ref60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","article-title":"Genetic and transcriptional evolution alters cancer cell line drug response","volume":"560","author":"Ben-David","year":"2018","journal-title":"Nature"},{"key":"2021110815072724900_ref61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cels.2020.08.012","article-title":"Assessment of genetic drift in large pharmacogenomic studies","volume":"11","author":"Quevedo","year":"2020","journal-title":"Cell Syst"},{"key":"2021110815072724900_ref62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12551-018-0446-z","article-title":"Machine learning and feature selection for drug response prediction in precision oncology applications","volume":"11","author":"Ali","year":"2019","journal-title":"Biophys Rev"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/22\/6\/bbab294\/41088388\/bbab294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/22\/6\/bbab294\/41088388\/bbab294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T16:21:26Z","timestamp":1672762886000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab294\/6348324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab294","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.09.439076","asserted-by":"object"}]},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,8,11]]},"article-number":"bbab294"}}